Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

IRONWOOD PHARMACEUTICALS, INC.

(IRWD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 05:04pm EDT
asure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid"> </div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"> </p>

<p style="text-align: center; margin: 0pt 0; font: 18pt Times New Roman, Times, Serif"><b>UNITED STATES</b></p>

<p style="text-align: center; margin: 0pt 0; font: 18pt Times New Roman, Times, Serif"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="text-align: center; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p>

<p style="text-align: center; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Washington, D.C. 20549</b></p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p>


<p style="text-align: center; margin: 0pt 0; font: 18pt Times New Roman, Times, Serif"><b>FORM <span id="xdx_900_edei--DocumentType_c20190813__20190814_zGh7ovrkOMz"><ix:nonNumeric contextRef="From2019-08-13to2019-08-14" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p>

<p style="text-align: center; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Current Report Pursuant to</b></p>

<p style="text-align: center; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Section 13 or 15(d) of the</b></p>

<p style="text-align: center; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Securities Exchange Act of 1934</b></p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p>

<p style="text-align: center; m

13__20190814_zigdaL6OmiM2"><ix:nonNumeric

contextRef="From2019-08-13to2019-08-14" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 14, 2019</ix:nonNumeric></span></b></p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p>


<p style="text-align: center; margin: 0pt 0; font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityRegistrantName_c20190813__20190814_zT7ehdY7Pmok"><ix:nonNumeric contextRef="From2019-08-13to2019-08-14" name="dei:EntityRegistrantName">IRONWOOD PHARMACEUTICALS, INC.</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">(Exact name of registrant as specified in its charter)</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> </p>

<td style="vertical-align: top; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20190813__20190814_zGYRMe5uyGL8"><ix:nonNumeric contextRef="From2019-08-13to2019-08-14" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>

<td style="vertical-align: bottom; width: 1%"> </td>

<td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityFileNumber_c20190813__20190814_zZw63fYp1MX1"><ix:nonNumeric contextRef="From2019-08-13to2019-08-14" name="dei:EntityFileNumber">001-34620</ix:nonNumeric></span></b></span></td>

<td style="vertical-align: bottom; width: 1%"> </td>

<td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20190813__20190814_z1hgKRLHMIy5"><ix:nonNumeric contextRef="From2019-08-13to2019-08-14" name="dei:EntityTaxIdentificationNumber">04-3404176</ix:nonNumeric></span></b></span></td></tr>

<td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction</span></td>

<td style="vertical-align: bottom"> </td>

<td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Com

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IRONWOOD PHARMACEUTICALS,
08/14IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unreg..
AQ
08/14ALNYLAM PHARMACEUTICALS : and Ironwood Pharmaceuticals Enter U.S. GI Disease Edu..
AQ
08/13IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Creat..
AQ
08/13IRONWOOD PHARMACEUTICALS : Announces Full Exercise of Convertible Notes Over-All..
BU
08/13ALNYLAM PHARMACEUTICALS : and Ironwood Pharmaceuticals Enter U.S. GI Disease Edu..
BU
08/08IRONWOOD PHARMACEUTICALS : Announces Pricing of Upsized $350 Million Convertible..
BU
08/06IRONWOOD PHARMACEUTICALS : Announced Proposed Offering of $330 Million of Conver..
BU
08/01IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Regul..
AQ
07/30IRONWOOD : 2Q Earnings Snapshot
AQ
07/30IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
AQ
More news
Financials (USD)
Sales 2019 379 M
EBIT 2019 53,3 M
Net income 2019 -5,71 M
Debt 2019 224 M
Yield 2019 -
P/E ratio 2019 -218x
P/E ratio 2020 16,3x
EV / Sales2019 4,22x
EV / Sales2020 3,71x
Capitalization 1 372 M
Chart IRONWOOD PHARMACEUTICALS, INC.
Duration : Period :
Ironwood Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IRONWOOD PHARMACEUTICALS,
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 14,19  $
Last Close Price 8,77  $
Spread / Highest target 117%
Spread / Average Target 61,8%
Spread / Lowest Target 8,32%
EPS Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
William I. Huyett Chief Operating Officer
Gina R. Consylman CFO, CAO, Controller & SVP-Finance
Mark G. Currie Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICALS, INC.-15.35%1 404
IQVIA HOLDINGS INC33.61%29 805
LONZA GROUP34.43%25 750
INCYTE CORPORATION30.71%17 337
CELLTRION, INC.--.--%16 155
EXACT SCIENCES CORPORATION87.35%15 308